Modulo

Modulo Bio is a San Diego, California biotechnology company reprogramming the neuroimmune system to overcome the world's toughest neurological diseases. The company develops therapeutics that target microglia, the brain's resident immune cells, by combining stem cell engineering, neurobiology, multiomics (CRISPR and single-cell techniques), and machine learning to understand and manipulate microglial behavior, identify biomarkers, and discover new drug candidates. Modulo Bio is a therapeutics research company and does not currently publish a public developer platform, API, or technical documentation; this profile captures its identity and domain-security posture.

Modulo is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Neuroscience, and Drug Discovery.

🌐 Visit website 📡 Source on GitHub

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcareBiotechnologyNeuroscienceDrug DiscoveryTherapeuticsNeuroimmunologyMachine Learning

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 7.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/modulo: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: modulo
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/modulo.png
name: Modulo
description: Modulo Bio is a San Diego, California biotechnology company reprogramming the neuroimmune system to overcome
  the world's toughest neurological diseases. The company develops therapeutics that target microglia, the brain's resident
  immune cells, by combining stem cell engineering, neurobiology, multiomics (CRISPR and single-cell techniques), and machine
  learning to understand and manipulate microglial behavior, identify biomarkers, and discover new drug candidates. Modulo
  Bio is a therapeutics research company and does not currently publish a public developer platform, API, or technical documentation;
  this profile captures its identity and domain-security posture.
url: https://raw.githubusercontent.com/api-evangelist/modulo/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- initialized-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Healthcare
- Biotechnology
- Neuroscience
- Drug Discovery
- Therapeutics
- Neuroimmunology
- Machine Learning
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/modulo-domain-security.yml
- type: Website
  url: https://modulo.bio/
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1

Modulo

Kin Score

Security Posture 1

Modulo Domain Security

Resources

Access & Security 1

Company 1

Source (apis.yml)